[...] from the Merck Serono division to the Consumer Health division. A detailed presentation of the resulting disclosure changes in segment reporting can be found in the information on segment reporting. The notes to the consolidated financial statements of the Merck Group for 2013, particularly the accounting policies, apply accordingly. Income tax include the taxes on taxable profit levied in the individual countries plus changes in deferred taxes recognized in income. The income tax in the interim financial statements is calculated based on the income of the consolidated companies and the currently valid tax rate as a best possible estimate. The preparation of the [...]

[...] 2014 Q1 – 2013 Change in % Total revenues 2,664.8 2,760.5 –3.5 Sales 2,613.9 2,660.4 –1.7 Operating result (EBIT) 468.3 399.4 17.3 Margin (% of sales) 17.9 15.0 EBITDA 770.2 753.8 2.2 Margin (% of sales) 29.5 28.3 EBITDA pre one-time items 807.1 801.1 0.7 Margin (% of sales) 30.9 30.1 Earnings per share (€) 1.50 1.22 23.0 Earnings per share pre one-time items (€) 2.31 2.11 9.5 Business free cash flow 684.1 592.9 15.4 Development of total revenues and sales as well as results of operations In the first quarter of 2014, total revenues of the Merck Group grew organically by 1.8%, which was outweighed by negative foreign exchange effects of –5.3%. Overall, [...]

XLS Merck Serono | Key figures € million Q1 – 2014 Q1 – 2013* Change in % * The previous year’s figures have been adjusted, see “The Merck Group and its divisions”. Total revenues 1,421.1 1,482.1 –4.1 Sales 1,374.9 1,388.8 –1.0 Operating result (EBIT) 235.8 170.2 38.5 Margin (% of sales) 17.2 12.3 EBITDA 428.0 408.3 4.8 Margin (% of sales) 31.1 29.4 EBITDA pre one-time items 438.0 437.7 0.1 Margin (% of sales) 31.9 31.5 Business free cash flow 480.0 340.0 41.2 Development of total revenues and sales as well as results of operations In the first quarter of 2014, total revenues of the Merck Serono division grew organically by 0.8%. However, owing to [...]

XLS Performance Materials | Key figures € million Q1 – 2014 Q1 – 2013 Change in % Total revenues 402.7 422.1 –4.6 Sales 402.2 421.3 –4.5 Operating result (EBIT) 151.7 172.5 –12.1 Margin (% of sales) 37.7 41.0 EBITDA 178.8 203.3 –12.0 Margin (% of sales) 44.5 48.3 EBITDA pre one-time items 186.4 207.4 –10.1 Margin (% of sales) 46.3 49.2 Business free cash flow 165.5 199.0 –16.8 Development of total revenues and sales as well as results of operations In the first quarter of 2014, the Performance Materials division achieved a slight 1.1% organic increase in sales, despite a strong year-earlier quarter. Considerable currency headwinds of –5.6%, [...]

XLS Merck Millipore | Key figures € million Q1 – 2014 Q1 – 2013 Change in % Total revenues 660.4 674.5 –2.1 Sales 656.5 668.7 –1.8 Operating result (EBIT) 87.0 72.3 20.3 Margin (% of sales) 13.3 10.8 EBITDA 163.7 151.5 8.1 Margin (% of sales) 24.9 22.7 EBITDA pre one-time items 169.7 161.9 4.8 Margin (% of sales) 25.8 24.2 Business free cash flow 54.4 81.1 –32.9 Development of total revenues and sales as well as results of operations The Merck Millipore division generated organic sales growth of 3.7% in the first quarter of 2014. This organic growth was countered by a negative foreign exchange impact of –5.5%, which primarily stemmed from the Japanese [...]